Status:
COMPLETED
Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation
Lead Sponsor:
University of Pennsylvania
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study involves treatment for atrial fibrillation (AF)-the most common heart condition in the US-where the upper chambers of the heart beat very fast and in a disorganized manner. This can be felt...
Detailed Description
In most cases, AF originates where the pulmonary veins (PV) enter the left upper chamber of the heart, known as the left atrium (LA). Common to the procedure in each arm of the study is pulmonary vein...
Eligibility Criteria
Inclusion
- All patients of age ≥ 30 years, undergoing their first ablation procedure that meet ACC / AHA defined criteria for persistent or permanent AF will be eligible to participate in the study. This includes patients with a history of AF episodes lasting at least 7 days or requiring at least 2 cardioversions.
Exclusion
- Patients with paroxysmal AF (self-terminating episodes lasting \< 7 day)
- Patients who have had a previous AF ablation procedure
- Pregnancy
- Failure to obtain informed consent
- Less than 30 years old
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT00379301
Start Date
October 1 2006
End Date
October 1 2011
Last Update
June 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States, 19104